SAB Capra Awarded $225K from NIH to Broaden Novel Immunotherapy Platform – Business Wire (press release)
SAB Capra Awarded $225K from NIH to Broaden Novel Immunotherapy PlatformBusiness Wire (press release)SAB Capra, LLC is a privately-held, emerging bioscience company leveraging transgenic goats for the production of human polyclonal antibodies for use i… Continue reading
